by Rawamino | Oct 24, 2025 | Peptides
Introduction Age-associated vision decline and retina-focused pathologies (e.g., diabetic retinopathy and neovascular disorders) continue to challenge researchers due to overlapping vascular, inflammatory, and neurodegenerative mechanisms. Conventional approaches...
by Rawamino | Oct 23, 2025 | Peptides
Introduction Inflammation is a coordinated, multi-tissue response that may restore homeostasis after injury or infection; however, when dysregulated or prolonged it can contribute to tissue damage, fibrosis, and systemic comorbidities. Contemporary research often...
by Rawamino | Oct 23, 2025 | Peptides
Introduction Myocardial infarction (MI) and the ensuing fibrotic remodeling appear to arise from convergent mechanisms that include acute sterile inflammation, oxidative stress, and altered cellular turnover within the myocardium. Experimental work suggests that...
by Rawamino | Oct 22, 2025 | Peptides
Introduction Alzheimer’s disease (AD) is a complex neurodegenerative disorder characterized by progressive cognitive decline, memory impairment, and neuronal loss. While the accumulation of amyloid beta (Aβ) plaques remains one of the most widely studied features of...
by Rawamino | Oct 22, 2025 | Peptides
Introduction GHK-Cu (glycyl-L-histidyl-L-lysine–copper) is a small, copper-binding tripeptide that was first described in human plasma and later detected across multiple tissues. Early observations suggested that endogenous levels may decline with age, prompting...
by Rawamino | Oct 21, 2025 | Peptides
Introduction In recent years, peptides have become a focal point in hair growth research due to their capacity to influence signaling pathways that regulate vascularization, inflammation, and cellular turnover. Earlier studies offered only fragmentary insights into...
